EpiAxis
  • Home
  • About us
    • Introduction
    • Board
    • Management & advisers
    • Collaborators
  • Our science
    • Epigenetics & cancer simplified
    • EpiAxis science in detail
    • Our pipeline & IP
    • Clinical trial
    • Publications
  • Our news
  • Contact
Select Page

Collaborators

NOVEMBER 2022

EpiAxis enters agreement with Seattle Children’s Research Institute

SEPTEMBER 2022

EpiAxis enters strategic partnership with UHN

AUGUST 2022

EpiAxis & Peptilogics enter strategic drug discovery partnership

DECEMBER 2021

EpiAxis expands its PKC theta pre-clinical program with Mount Sinai

Copyright © 2021 - EpiAxis Therapeutics | Privacy Policy